Immuron Limited Issues Over 1 Million New Shares
I'm PortAI, I can summarize articles.
Immuron Limited has issued 1,142,909 ordinary shares without disclosure under Part 6D.2 of the Corporations Act. This move adheres to regulatory requirements and aims to enhance the company's financial position and operational capabilities. The latest analyst rating for Immuron Limited stock is a Hold with a A$0.04 price target. Immuron operates in the biotechnology industry, focusing on oral immunotherapeutics for gut-mediated diseases. The company's YTD price performance is -50.63%, with an average trading volume of 1,056,012 and a current market cap of A$12.68M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments